ViiV Healthcare's Rukobia will treat HIV-positive people dealing with drug resistance or intolerance.
A sweeping study found HIV-positive people adhering to their regimens are less at risk of serious repercussions from COVID-19.
Nations must address the problem now, warned The Joint United Nations Programme on HIV/AIDS.
Probation officials and a judge weren't impressed with the "Pharma bro," who's now a convicted fraudster.
A federal study found Gilead's remdesivir cut recovery time in some COVID-19 patients.
Study finds increased weight gains with newer antiretroviral drugs.
For virally-suppressed HIV-positive people, Cabenuva could replace a daily pill.